The introduction of a drug into the human body for the first time is an important milestone; largely because information elicited from human safety and early efficacy testing drives the "go/no-go" decisions for further development.
Reap the benefits of more than 30 years of experience in managing the transition from nonclinical to clinical studies from Covance, a leader in human safety and early efficacy testing.
- Gain insight on the viability of your drug candidate from our extensive experience in all study types and therapeutic areas
- Target milestones with strategies designed for go/no-go decisions in the most expeditious, economic manner possible
- Maintain a competitive edge with Covance as we provide you with access to comprehensive support services, clinical site choices in the United States or Europe, and a large, diverse study population